HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications

Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening

(2011) Dorien C. Rijkaart et al.   INTERNATIONAL JOURNAL OF CANCER

Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection

(2010) A. C. Rodriguez et al.   JNCI-Journal of the National Cancer Institute

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

(2010) Guglielmo Ronco et al.   LANCET ONCOLOGY

Trends of cervical cancer mortality in the member states of the European Union

(2009) Marc Arbyn et al.   EUROPEAN JOURNAL OF CANCER

Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis

(2009) Renée M Overmeer et al.   JOURNAL OF PATHOLOGY

Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized Setting

(2009) Maarit Leinonen et al.   JNCI-Journal of the National Cancer Institute

Is the UK ready to embrace HPV testing?

(2009) Eduardo L Franco   LANCET ONCOLOGY

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial

(2009) Henry C Kitchener et al.   LANCET ONCOLOGY

Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC

(2008) RM Overmeer et al.   JOURNAL OF PATHOLOGY

Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 Vaccination

(2008) J. D. Goldhaber-Fiebert et al.   JNCI-Journal of the National Cancer Institute

Results at Recruitment From a Randomized Controlled Trial Comparing Human Papillomavirus Testing Alone With Conventional Cytology as the Primary Cervical Cancer Screening Test

(2008) G. Ronco et al.   JNCI-Journal of the National Cancer Institute